Correlation between D-dimer and first-ever acute ischemic stroke (AIS) severity in Dr. Sardjito General Hospital, Yogyakarta
Abstract
Acute ischemic stroke (AIS) continuing to be an entity causing morbidity and mortality worldwide. The National Institutes of Health Stroke Scale (NIHSS) is a largely used as clinical assessment instrument to measure neurological deficit of stroke. Studies concerned that D-dimer, a fibrin degradation product, has as a potential biomarker in predicting stroke severity and prognosis. This study aimed to investigate the correlation between D-dimer levels and NIHSS score in patients with a first-ever AIS. This cross-sectional study used the stroke registry data of the Dr. Sardjito General Hospital, Yogyakarta from October 2021 to December 2022. A total 83 patients who met the inclusion and exclusion criteria were involved. The blood D-dimer level was measured during admission. The NIHSS scores were assessed within 24 hr of admission. The correlation between D-dimer levels and NIHSS scores were analysed using Spearman’s test. Multiple analysis was performed to evaluate the association of non-dependent risk factors using multiple logistic regression. The mean age of subjects was 60.77±11.08 yr, with a slightly males predominant (54.2%). The mean value of NIHSS score was 6.59 ± 7.00 and D-dimer level was 712.02 ± 1159.2 ng/mL. A significant positive correlation between D-dimer and NIHSS score (r= 0.475; p= 0.01) was observed. Furthermore, D-dimer remained showing an independent association with on-admission NIHSS score (p= 0.026). In conclusion, D-dimer level in stroke patients is associated with more severe on-admission NIHSS score.
References
Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): Global stroke fact sheet 2022. Int J Stroke 2022; 17(1):18-29.
https://doi.org/10.1177/17474930211065917
Kementerian Kesehatan Republik Indonesia. Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional RISKESDAS 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembagan Kesehatan; 2019.
Finkelstein EA, Chay J, Bajpai S. The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS One 2014; 9(6):e99572.
https://doi.org/10.1371/journal.pone.0099572
Katan M, Luft A. Global burden of stroke. Semin Neurol 2018; 38(2):208-11.
https://doi.org/10.1055/s-0038-1649503
Soomro AY, Guerchicoff A, Nichols DJ, Suleman J, Dangas GD. The current role and future prospects of D-dimer biomarker. Eur Heart J Cardiovasc Pharmacother 2016; 2(3):175-84.
https://doi.org/10.1093/ehjcvp/pvv039
Zhang J, Liu L, Tao J, Song Y, Fan Y, Gou M, et al. Prognostic role of early D-dimer level in patients with acute ischemic stroke. PLoS One 2019; 14(2):e0211458.
https://doi.org/10.1371/journal.pone.0211458
Nam KW, Kwon HM, Lee YS. Clinical significance of D-dimer levels during acute period in ischemic stroke. Thrombosis J 2023; 21(1):55.
https://doi.org/10.1186/s12959-023-00496-1
Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 2020; 13(11):1265-75.
https://doi.org/10.1080/17474086.2020.1831383
Park YW, Koh EJ, Choi HY. Correlation between serum D-dimer level and volume in acute ischemic stroke. J Korean Neurosurg Soc 2011; 50(2):89-94.
https://doi.org/10.3340/jkns.2011.50.2.89
Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother 2014; 60(1):61.
https://doi.org/10.1016/j.jphys.2013.12.012
Zhuo Y, Wu J, Qu Y, Yu H, Huang X, Zee B, et al. Clinical risk faktors associated with recurrence of ischemic stroke within two years: A cohort study. Medicine (Baltimore) 2020; 99(26):e20830.
https://doi.org/10.1097/MD.0000000000020830
Bounds EJ, Kok SJ. D Dimer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
https://www.ncbi.nlm.nih.gov/books/NBK431064/
Sila D, Marinovic M, Vojtková M, Kirsch P, Rath S, Charvát F. The good clinical outcome for patients with acute ischemic stroke treated with mechanical thrombectomy-does time still matter? Clin Trans Neurosci 2023; 7(3):9.
https://doi.org/10.3390/ctn7030029
Hou H, Xiang X, Pan Y, Li H, Meng X, Wang Y. Association of level and increase in D-dimer with all-cause death and poor functional outcome after ischemic stroke or transient ischemic attack. J Am Heart Assoc 2021; 10(3):e018600.
https://doi.org/10.1161/JAHA.120.018600
Sienkiewicz-Jarosz H, Galecka-Wolska M, Bidzinski A, Turzynska D, Sobolewska A, Lipska B, et al. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients. Neurol Neurochir Pol 2009; 43(2):126-33.
Liu Y, Li F, Sun H, Sun Y, Sun H, Zhai Y, et al. Combined prognostic significance of D-dimer level and platelet count in acute ischemic stroke. Thromb Res 2020; 194:142-9.
https://doi.org/10.1016/j.thromres.2020.05.021
Nardi K, Milia P, Eusebi P, Paciaroni M, Caso V, Agnelli G. Admission leukocytosis in acute cerebral ischemia: influence on early outcome. J Stroke Cerebrovasc Dis 2012; 21(8):819-24.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.04.015
Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S. Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis 2013; 22(7):e111-7.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.08.008
Lee KJ, Lee JS, Jung KH. Interactive effect of acute and chronic glycemic indexes for severity in acute ischemic stroke patients. BMC Neurol 2018; 18(1):105.
